[go: up one dir, main page]

DK1007061T3 - Fremgangsmåde til fremstilling af blodpladevækstfaktorekstrakt til sårhelingspræparater - Google Patents

Fremgangsmåde til fremstilling af blodpladevækstfaktorekstrakt til sårhelingspræparater

Info

Publication number
DK1007061T3
DK1007061T3 DK97908091T DK97908091T DK1007061T3 DK 1007061 T3 DK1007061 T3 DK 1007061T3 DK 97908091 T DK97908091 T DK 97908091T DK 97908091 T DK97908091 T DK 97908091T DK 1007061 T3 DK1007061 T3 DK 1007061T3
Authority
DK
Denmark
Prior art keywords
platelets
growth factor
wound healing
platelet
platelet growth
Prior art date
Application number
DK97908091T
Other languages
Danish (da)
English (en)
Inventor
Paul Brazeau
Thierry Abribat
Michel Ibea
Michele Boushira
Original Assignee
Theratechnologies Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Theratechnologies Inc filed Critical Theratechnologies Inc
Application granted granted Critical
Publication of DK1007061T3 publication Critical patent/DK1007061T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/39Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14Blood; Artificial blood
    • A61K35/19Platelets; Megacaryocytes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18Growth factors; Growth regulators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/38Albumins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Zoology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Virology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DK97908091T 1996-03-20 1997-03-19 Fremgangsmåde til fremstilling af blodpladevækstfaktorekstrakt til sårhelingspræparater DK1007061T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/618,560 US5834418A (en) 1996-03-20 1996-03-20 Process for the preparation of platelet growth factors extract

Publications (1)

Publication Number Publication Date
DK1007061T3 true DK1007061T3 (da) 2004-06-14

Family

ID=24478208

Family Applications (1)

Application Number Title Priority Date Filing Date
DK97908091T DK1007061T3 (da) 1996-03-20 1997-03-19 Fremgangsmåde til fremstilling af blodpladevækstfaktorekstrakt til sårhelingspræparater

Country Status (8)

Country Link
US (1) US5834418A (fr)
EP (1) EP1007061B1 (fr)
AT (1) ATE259238T1 (fr)
AU (1) AU725091B2 (fr)
CA (1) CA2249534A1 (fr)
DE (1) DE69727595T2 (fr)
DK (1) DK1007061T3 (fr)
WO (1) WO1997034614A1 (fr)

Families Citing this family (80)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6528483B2 (en) 1995-06-07 2003-03-04 André Beaulieu Method of producing concentrated non-buffered solutions of fibronectin
US7112320B1 (en) 1995-06-07 2006-09-26 Andre Beaulieu Solid wound healing formulations containing fibronectin
US6102926A (en) 1996-12-02 2000-08-15 Angiotrax, Inc. Apparatus for percutaneously performing myocardial revascularization having means for sensing tissue parameters and methods of use
US6120520A (en) 1997-05-27 2000-09-19 Angiotrax, Inc. Apparatus and methods for stimulating revascularization and/or tissue growth
US6051008A (en) 1996-12-02 2000-04-18 Angiotrax, Inc. Apparatus having stabilization members for percutaneously performing surgery and methods of use
AT407484B (de) * 1997-11-12 2001-03-26 Bio Prod & Bio Eng Ag Arzneimittel zur förderung der wundheilung
US6432119B1 (en) 1999-03-17 2002-08-13 Angiotrax, Inc. Apparatus and methods for performing percutaneous myocardial revascularization and stimulating angiogenesis using autologous materials
US20010041792A1 (en) * 2000-02-03 2001-11-15 Donda Russell S. Extraction of growth factors from tissue
EP1301228B1 (fr) 2000-07-13 2008-07-23 Abbott Cardiovascular Systems Inc. Systeme de deploiement destine a un materiau cellulaire du myocarde
US8101077B2 (en) * 2001-05-07 2012-01-24 Sivaprasad Sukavaneshvar Device for separating platelets from fluid suspensions
US7011852B2 (en) * 2001-05-07 2006-03-14 Hemogenesis, Llc Separation of platelets from whole blood for use as a healant
US7608258B2 (en) * 2002-04-13 2009-10-27 Allan Mishra Method for treatment of tendinosis using platelet rich plasma
US6811777B2 (en) * 2002-04-13 2004-11-02 Allan Mishra Compositions and minimally invasive methods for treating incomplete connective tissue repair
US6905612B2 (en) * 2003-03-21 2005-06-14 Hanuman Llc Plasma concentrate apparatus and method
US20030205538A1 (en) 2002-05-03 2003-11-06 Randel Dorian Methods and apparatus for isolating platelets from blood
US7374678B2 (en) 2002-05-24 2008-05-20 Biomet Biologics, Inc. Apparatus and method for separating and concentrating fluids containing multiple components
US7179391B2 (en) 2002-05-24 2007-02-20 Biomet Manufacturing Corp. Apparatus and method for separating and concentrating fluids containing multiple components
US7832566B2 (en) 2002-05-24 2010-11-16 Biomet Biologics, Llc Method and apparatus for separating and concentrating a component from a multi-component material including macroparticles
US7992725B2 (en) 2002-05-03 2011-08-09 Biomet Biologics, Llc Buoy suspension fractionation system
US7845499B2 (en) 2002-05-24 2010-12-07 Biomet Biologics, Llc Apparatus and method for separating and concentrating fluids containing multiple components
US20060278588A1 (en) 2002-05-24 2006-12-14 Woodell-May Jennifer E Apparatus and method for separating and concentrating fluids containing multiple components
US8308708B2 (en) 2003-07-15 2012-11-13 Abbott Cardiovascular Systems Inc. Deployment system for myocardial cellular material
US7678780B2 (en) * 2003-12-29 2010-03-16 Allan Mishra Method of treating cancer using platelet releasate
US20070110737A1 (en) * 2003-12-29 2007-05-17 Allan Mishra Compositions and method for decreasing the appearance of skin wrinkles
WO2005065419A2 (fr) * 2003-12-29 2005-07-21 Am Biosolutions Procede de culture de cellules
US20050191286A1 (en) * 2004-02-09 2005-09-01 Gandy James B. Lyophilized platelet rich plasma for the use in wound healing (chronic or acute) and bone or tissue grafts or repair
DE112004002847T5 (de) * 2004-05-05 2007-04-05 Synthes Gmbh Verwendung von Blutplättchen oder blutblättchenreichem Plasma (PRP)
US7462268B2 (en) 2004-08-20 2008-12-09 Allan Mishra Particle/cell separation device and compositions
ITRM20040638A1 (it) 2004-12-24 2005-03-24 Advance Holdings Ltd Gel piastrinico semisintetico e metodo per la sua preparazione.
JP4510898B2 (ja) 2005-02-07 2010-07-28 ハヌマン リミテッド ライアビリティ カンパニー 血漿濃縮装置
US7694828B2 (en) 2005-04-27 2010-04-13 Biomet Manufacturing Corp. Method and apparatus for producing autologous clotting components
US9074176B2 (en) 2006-01-13 2015-07-07 Two Cells Co., Ltd. Culture medium additive for use in serum-free culturing of animal cell, kit and use thereof
US8567609B2 (en) 2006-05-25 2013-10-29 Biomet Biologics, Llc Apparatus and method for separating and concentrating fluids containing multiple components
US8328024B2 (en) 2007-04-12 2012-12-11 Hanuman, Llc Buoy suspension fractionation system
JP5479319B2 (ja) 2007-04-12 2014-04-23 バイオメット・バイオロジックス・リミテッド・ライアビリティ・カンパニー ブイ式懸濁液分画システム
US9095562B2 (en) 2007-07-05 2015-08-04 Regenerative Sciences, Inc. Methods and compositions for optimized expansion and implantation of mesenchymal stem cells
WO2009052221A2 (fr) * 2007-10-15 2009-04-23 The Regents Of The University Of Colorado Procédés d'extraction de plaquettes et compositions obtenues à partir de ceux-ci
US20110200642A1 (en) 2007-12-19 2011-08-18 Regenerative Sciences, Llc Compositions and Methods to Promote Implantation and Engrafment of Stem Cells
US8835104B2 (en) 2007-12-20 2014-09-16 Fenwal, Inc. Medium and methods for the storage of platelets
EP2567692B1 (fr) 2008-02-27 2016-04-06 Biomet Biologics, LLC Utilisation d'un dispositif pour obtenir des solutions riches en antagoniste de récepteur d'interleukine-1
US8337711B2 (en) 2008-02-29 2012-12-25 Biomet Biologics, Llc System and process for separating a material
US20110052533A1 (en) 2008-03-14 2011-03-03 Regenerative Sciences, Llc Compositions and Methods for Cartilage Repair
EP2334785B2 (fr) 2008-09-16 2019-08-14 Mayo Foundation For Medical Education And Research Compositions à contenu plaquettaire
US20100112081A1 (en) * 2008-10-07 2010-05-06 Bioparadox, Llc Use of platelet rich plasma composition in the treatment of cardiac conduction abnormalities
JP2012505239A (ja) * 2008-10-09 2012-03-01 バイオパラドックス,リミテッド ライアビリティー カンパニー 心臓治療用の多血小板血漿製剤
JP5660572B2 (ja) 2008-11-11 2015-01-28 国立大学法人広島大学 分化誘導培地用添加剤およびその利用
US20110245804A1 (en) 2008-12-05 2011-10-06 Regenerative Sciences, Llc Methods and Compositions to Facilitate Repair of Avascular Tissue
US8187475B2 (en) 2009-03-06 2012-05-29 Biomet Biologics, Llc Method and apparatus for producing autologous thrombin
US20100233282A1 (en) * 2009-03-13 2010-09-16 Allan Mishra Device and methods for delivery of bioactive materials to the right side of the heart
US8313954B2 (en) 2009-04-03 2012-11-20 Biomet Biologics, Llc All-in-one means of separating blood components
EP2264150A1 (fr) * 2009-06-09 2010-12-22 Astley E. Smith Procédé de concentration de plaquettes à triple centrifugation, double mélange et redistribution et concentré plaquettaire ainsi dérivé
US9011800B2 (en) 2009-07-16 2015-04-21 Biomet Biologics, Llc Method and apparatus for separating biological materials
US9113950B2 (en) 2009-11-04 2015-08-25 Regenerative Sciences, Llc Therapeutic delivery device
JP5804385B2 (ja) 2010-03-10 2015-11-04 株式会社ツーセル 間葉系幹細胞を含む細胞製剤及びその製造方法
US8591391B2 (en) 2010-04-12 2013-11-26 Biomet Biologics, Llc Method and apparatus for separating a material
EP2694131B1 (fr) 2011-04-07 2019-08-28 Fenwal, Inc. Procédés et systèmes automatisés pour produire des concentrés de plaquettes avec des volumes de plasma résiduel réduits et des milieux de conservation pour de tels concentrés de plaquettes
AU2012275335B2 (en) 2011-06-29 2017-04-20 Biorestorative Therapies, Inc. Brown fat cell compositions and methods
US9682104B2 (en) * 2012-01-26 2017-06-20 Jadi Cell Llc Lyophilized platelet lysates
ES2438640B1 (es) * 2012-07-16 2014-11-25 Laboratorios Miramon, S.L. Composición para la regeneración y reparación de la piel
US9642956B2 (en) 2012-08-27 2017-05-09 Biomet Biologics, Llc Apparatus and method for separating and concentrating fluids containing multiple components
EP2948210A4 (fr) * 2013-01-28 2016-10-19 Regenerative Sciences Llc Dispositif et procédés utilisables en vue de la lyse ou de l'activation de plaquettes sanguines
US10905721B2 (en) 2013-01-28 2021-02-02 Regenexx, Llc. Device and methods for platelet lysis or activation
US9950035B2 (en) 2013-03-15 2018-04-24 Biomet Biologics, Llc Methods and non-immunogenic compositions for treating inflammatory disorders
US10143725B2 (en) 2013-03-15 2018-12-04 Biomet Biologics, Llc Treatment of pain using protein solutions
US20140271589A1 (en) 2013-03-15 2014-09-18 Biomet Biologics, Llc Treatment of collagen defects using protein solutions
US9895418B2 (en) 2013-03-15 2018-02-20 Biomet Biologics, Llc Treatment of peripheral vascular disease using protein solutions
US10208095B2 (en) 2013-03-15 2019-02-19 Biomet Manufacturing, Llc Methods for making cytokine compositions from tissues using non-centrifugal methods
US20140356893A1 (en) 2013-06-04 2014-12-04 Allan Mishra Compositions and methods for using platelet-rich plasma for drug discovery, cell nuclear reprogramming, proliferation or differentiation
EP2813232B1 (fr) * 2013-06-11 2017-08-09 DOT GmbH Procédé de production d'extrait de facteur de croissance allogène
HK1194912A2 (en) * 2013-09-17 2014-10-24 Bestop Group Holdings Ltd Growth factor concentrate and the use thereof
US9550028B2 (en) 2014-05-06 2017-01-24 Biomet Biologics, LLC. Single step desiccating bead-in-syringe concentrating device
EP4328299A3 (fr) 2014-05-16 2024-05-29 Mayo Foundation for Medical Education and Research Compositions de milieux de culture cellulaire pour cellules primaires
CA2987872A1 (fr) 2015-05-29 2016-12-08 Amit Patel Compositions de lysat de plaquettes lyophilisees particulaires
HRP20240919T8 (hr) * 2016-11-18 2024-10-25 Power Of Platelets Pte. Ltd. Postupak za pripremu sadržaja oslobođenog iz trombocita, koji sadrži faktore rasta, i njegove uporabe
CN110325226B (zh) * 2016-12-22 2022-03-15 瑞金尼克斯有限责任公司 用于血小板裂解或激活的设备和方法
CA3078625C (fr) 2017-10-09 2023-01-17 Terumo Bct Biotechnologies, Llc Recipient de lyophilisation et son procede d'utilisation
RU2710367C2 (ru) * 2018-05-29 2019-12-26 Общество с ограниченной ответственностью "Институт биотехнологий и фармакологии", ООО "ИНБИОФАРМА" Способ получения цитокинов из тромбоцитов пуповинной крови как субстрата для разработки лекарственных средств для человека и животных
CA3224729A1 (fr) 2019-03-14 2020-09-17 Terumo Bct Biotechnologies, Llc Ensemble et systeme de plateau de chargement pour lyophilisation
IT201900005978A1 (it) * 2019-04-17 2020-10-17 Claudio Migliaresi Composizione topica per il trattamento di ferite, ulcere e piaghe comprendente lisato piastrino preparata al momento dell’uso in condizioni di sterilità e dispositivo per tale preparazione
TWI857807B (zh) * 2020-03-20 2024-10-01 台灣粒線體應用技術股份有限公司 含有粒線體之組合物及其用於作為皮膚纖維母細胞活性促進劑之用途

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0383363A3 (fr) * 1984-11-29 1990-10-03 Regents Of The University Of Minnesota Application d'agents pour la guérison de blessures
JPH0653759B2 (ja) * 1986-02-17 1994-07-20 日本ケミカルリサ−チ株式会社 腫瘍細胞増殖抑制および殺腫瘍細胞因子の製造法
AU7988594A (en) * 1993-12-08 1995-06-27 Universite De Montreal Process for the preparation of serum and platelet growth factors extract

Also Published As

Publication number Publication date
WO1997034614A1 (fr) 1997-09-25
US5834418A (en) 1998-11-10
ATE259238T1 (de) 2004-02-15
EP1007061A1 (fr) 2000-06-14
DE69727595T2 (de) 2004-12-16
CA2249534A1 (fr) 1997-09-25
AU725091B2 (en) 2000-10-05
EP1007061B1 (fr) 2004-02-11
DE69727595D1 (de) 2004-03-18
AU2019597A (en) 1997-10-10

Similar Documents

Publication Publication Date Title
DK1007061T3 (da) Fremgangsmåde til fremstilling af blodpladevækstfaktorekstrakt til sårhelingspræparater
DK284986A (da) Antigen og virus, fremgangsmaade til fremstilling af antigenet, anvendelse af antigener ved fremstilling af immunogene praeparater eller til diagnose af antistoffer mod viruset
DK93388D0 (da) Lav-virusvarianter, dna- og proteinbestanddele deraf og anvendelse deraf, saerlig til diagnostiske formaal og til fremstilling af immunogene praeparater
AU9052891A (en) Proteins with changed epitopes and methods for the production thereof
EA200401467A1 (ru) Пептиды, полученные из казеина, и их применение в терапии
DE58900776D1 (de) Verfahren zur herstellung von apolipoproteinen aus blutplasma- oder serumfraktionen.
NO20001949D0 (no) Viral fjerningsprosess
AU2445888A (en) Recombinant fowlpox virus, vectors for the expression of heterologous proteins and vaccines for poultry derived from this virus
ATE130198T1 (de) Herstellung eines virus und reinigung von virenüberzugsproteinen zur impfstoffverwendung.
DE69325948D1 (de) Entfernung von Antikörpern aus von Blut stammenden Zusammensetzungen unter Erhalt von Gerinnungsfaktoren
EP0342860A3 (fr) Nouvelle protéine, séquences contenant le gène de cette protéine, vecteurs, procédés de préparation et utilisation
DE69009614D1 (de) Verfahren zur Herstellung von (S)-gamma-Hydroxymethyl-alpha,beta-Butenolid.
DE3886213D1 (de) Verfahren zur Herstellung von Antioxidant-Zubereitungen.
ATE112317T1 (de) Bcrf1-proteine als inhibitoren von interferon- g(g).
MX9206960A (es) Alboagreginas:agonistas de las plaquetas que se ligan a la glicoproteina ib de la membrana de las plaquetas
NO904292D0 (no) Fremgangsmaate for fremstilling av antikoagulerende peptider.
DE69131253D1 (de) Zur behandlung von tumoren und hiv-infektionen nützliches pflanzliches protein
FI880636A7 (fi) Menetelmä vaipallisten virusten inaktivoimiseksi solun avulla in vitro valmistetuissa proteiinivalmisteissa.
TOKUTAKE et al. Each component of neurofilament assembles itself to make component-specific filament
DE59004380D1 (de) Verfahren zur Herstellung von alpha-Fluoracrylsäurederivaten und neue 1,1-Difluor-2-halogenethyl-(halogen) methyl-ketone.
DE68911603D1 (de) Verfahren zur Herstellung von 2-Pyrrolidon.
DE69929683D1 (de) Antisense modulierung von lfa-3
DE59103040D1 (de) Verfahren zur Herstellung von symmetrischen 2,2'-Methylen-bis-benztriazolylphenolen.
DK59785A (da) Fremgangsmaade til fremstilling af i det vaesentlige fibrinogenfrit ahf
ATE9906T1 (de) Verfahren zum herstellen und erhalten von anaphylatoxin und cocytotaxin enthaltenden leukotaxin-praeparaten und von anaphylatoxinund cocytotaxin-proteinen in einer molekular homogenen und biologisch aktiven form.